Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Can We Reduce Diabetes-Related Lower Limb Amputations?
Sarah Johnson-Lynn1,2, Mohamed Abdelrahman1, Mona Abouzaid1
1The William Kelly Diabetes Centre, The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Abstract:
Lower extremity amputation is the most feared complication in people living with diabetes and produces a significant physical, psychosocial and economic burden. The annual cost of diabetes-related ulceration and amputation is £837-£962 million, i.e., 0.8-0.9% of the National Health Service budget for England. Major amputation rates have reduced globally, largely in association with the introduction of diabetes foot multidisciplinary team services. However, more recently, amputation rates have stagnated in the UK and started to increase again in the USA, driven by increased amputation rates in younger patients and those from areas of greater social deprivation. We discuss interventions shown to reduce lower limb amputation in diabetes including multidisciplinary team services, root cause analysis, prompt referral for expert assessment and whole systems approaches designed to improve diabetic foot care throughout the patient experience. Some recent novel clinical interventions also demonstrate potential for greater limb preservation. We also discuss recent novel plastic and vascular surgery interventions and advanced dressing solutions, which show promise in improving limb salvage rates in the context of diabetic foot ulceration.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dipeptidyl Peptidase 4 Inhibitors
Peripheral Artery Disease III: Interprofessional Care
Diabetes: Symptoms, Diagnosis, and Complications

